Validation of mycobacterium tuberculosis Rv1681 protein as a diagnostic marker of active pulmonary tuberculosis

Journal of Clinical Microbiology

Volumn 51, Issue 5, 2013, Pages 1367-1373

  Pollock, Nira R ^a   Macovei, Lilia ^b   Kanunfre, Kelly ^b,g   Dhiman, Rakesh ^b   Restrepo, Blanca I ^c   Zarate, Izewlda ^c,h   Pino, Paula A ^c,i   Mora Guzman, Francisco ^d   Fujiwara, Ricardo T ^e   Michel, Gerd ^f   Kashino, Suely S ^b,j   Campos Neto, Antonio ^b  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b FORSYTH INSTITUTE   (United States)

^c UNIVERSITY OF TEXAS   (United States)

^d SECRETARÍA DE SALUD   (Mexico)

^e FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^f FOUNDATION FOR INNOVATIVE NEW DIAGNOSTICS   (Switzerland)

^g UNIVERSITY OF SÃO PAULO   (Brazil)

^h Mays Cancer Center at UT Health San Antonio   (United States)

ⁱ Unidad de Biología Celular y Molecular   (Colombia)

^j Institute Adolpho Lutz   (Brazil)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; BIOLOGICAL MARKER; IMMUNOGLOBULIN G ANTIBODY; POLYCLONAL ANTIBODY; RV1681 PROTEIN; UNCLASSIFIED DRUG; BACTERIAL ANTIGEN; BACTERIUM ANTIBODY; IMMUNOGLOBULIN G; RV1681 PROTEIN, MYCOBACTERIUM TUBERCULOSIS;

ANIMAL EXPERIMENT; ANTIBODY DETECTION; ARTICLE; CHAGAS DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; FEMALE; HUMAN; IMMUNOPRECIPITATION; LUNG TUBERCULOSIS; MASS SPECTROMETRY; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PEPTIDE ANALYSIS; PRIORITY JOURNAL; SCHISTOSOMIASIS; SKIN LEISHMANIASIS; URINE CULTURE; VALIDATION STUDY; AMINO ACID SEQUENCE; ESCHERICHIA COLI INFECTION; IMMUNOLOGY; ISOLATION AND PURIFICATION; METABOLISM; MOLECULAR GENETICS; TUBERCULOSIS, PULMONARY; URINE;

ESCHERICHIA COLI; MYCOBACTERIUM TUBERCULOSIS; ORYCTOLAGUS CUNICULUS;

AMINO ACID SEQUENCE; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BIOLOGICAL MARKERS; CHAGAS DISEASE; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; HUMANS; IMMUNOGLOBULIN G; LEISHMANIASIS, CUTANEOUS; MOLECULAR SEQUENCE DATA; MYCOBACTERIUM TUBERCULOSIS; SCHISTOSOMIASIS; TUBERCULOSIS, PULMONARY;

EID: 84876763881     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.03192-12     Document Type: Article

References (25)

1. World Health Organization. 2012. Global tuberculosis report 2012. World Health Organization, Geneva, Switzerland.
2. McNerney R, Maeurer M, Abubakar I, Marais B, McHugh TD, Ford N, Weyer K, Lawn S, Grobusch MP, Memish Z, Squire SB, Pantaleo G, Chakaya J, Casenghi M, Migliori GB, Mwaba P, Zijenah L, Hoelscher M, Cox H, Swaminathan S, Kim PS, Schito M, Harari A, Bates M, Schwank S, O'Grady J, Pletschette M, Ditui L, Atun R, Zumla A. 2012. Tuberculosis diagnostics and biomarkers: needs, challenges, recent advances, and opportunities. J. Infect. Dis. 205(Suppl 2):S147-S158.
3. World Health Organization. 2010. The global plan to stop TB 2011-2015. Publication no. WHO/HTM/STB/2010.2. World Health Organization, Geneva, Switzerland.
4. Steingart KR, Ng V, Henry M, Hopewell PC, Ramsay A, Cunningham J, Urbanczik R, Perkins MD, Aziz MA, Pai M. 2006. Sputum processing methods to improve the sensitivity of smear microscopy for tuberculosis: a systematic review. Lancet Infect. Dis. 6:664-674.
5. Steingart KR, Ramsay A, Pai M. 2007. Optimizing sputum smear microscopy for the diagnosis of pulmonary tuberculosis. Expert Rev. Anti Infect. Ther. 5:327-331.
6. Wallis RS, Pai M, Menzies D, Doherty TM, Walzl G, Perkins MD, Zumla A. 2010. Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice. Lancet 375:1920-1937.
7. Kashino SS, Pollock N, Napolitano DR, Rodrigues V, Jr, Campos-Neto A. 2008. Identification and characterization of Mycobacterium tuberculosis antigens in urine of patients with active pulmonary tuberculosis: an innovative and alternative approach of antigen discovery of useful microbial molecules. Clin. Exp. Immunol. 153:56-62.
8. Napolitano DR, Pollock N, Kashino SS, Rodrigues V, Jr, Campos-Neto A. 2008. Identification of Mycobacterium tuberculosis ornithine carboamyltransferase in urine as a possible molecular marker of active pulmonary tuberculosis. Clin. Vaccine Immunol. 15:638-643.
9. Restrepo BI, Camerlin AJ, Rahbar MH, Wang W, Restrepo MA, Zarate I, Mora-Guzman F, Crespo-Solis JG, Briggs J, McCormick JB, Fisher-Hoch SP. 2011. Cross-sectional assessment reveals high diabetes prevalence among newly-diagnosed tuberculosis cases. Bull. World Health Organ. 89:352-359.
10. Gomez DI, Mullin CS, Mora-Guzman F, Crespo-Solis JG, Fisher-Hoch SP, McCormick JB, Restrepo BI. 2011. Rapid DNA extraction for specific detection and quantitation of Mycobacterium tuberculosis DNA in sputum specimens using TaqMan assays. Tuberculosis (Edinb.) 91(Suppl 1):S43-S48.
11. Kent PT, Kubica GP. 1985. Public health mycobacteriology: a guide for the level III laboratory. Centers for Disease Control and Prevention, Atlanta, GA.
12. Butler WR, Jost KC, Jr, Kilburn JO. 1991. Identification of mycobacteria by high-performance liquid chromatography. J. Clin. Microbiol. 29: 2468-2472.
13. Restrepo BI, Gomez DI, Shipley GL, McCormick JB, Fisher-Hoch SP. 2006. Selective enrichment and detection of mycobacterial DNA in paucibacillary specimens. J. Microbiol. Methods 67:220-229.
14. Green NM, Konieczny L, Toms EJ, Valentine RC. 1971. The use of bifunctional biotinyl compounds to determine the arrangement of subunits in avidin. Biochem. J. 125:781-791.
15. Keeler E, Perkins MD, Small P, Hanson C, Reed S, Cunningham J, Aledort JE, Hillborne L, Rafael ME, Girosi F, Dye C. 2006. Reducing the global burden of tuberculosis: the contribution of improved diagnostics. Nature 444(Suppl 1):49-57.
16. World Health Organization. 2011. Global tuberculosis control 2011. World Health Organization, Geneva, Switzerland.
17. Weyer K, Carai S, Nunn P. 2011. Viewpoint TB diagnostics: what does the world really need? J. Infect. Dis. 204(Suppl 4):S1196-S1202.
18. Peter J, Green C, Hoelscher M, Mwaba P, Zumla A, Dheda K. 2010. Urine for the diagnosis of tuberculosis: current approaches, clinical applicability, and new developments. Curr. Opin. Pulm. Med. 16:262-270.
19. Mukherjee S, Daifalla N, Zhang Y, Douglass J, Brooks L, Vedvick T, Houghton R, Reed SG, Campos-Neto A. 2004. Potential serological use of a recombinant protein that is a replica of a Mycobacterium tuberculosis protein found in the urine of infected mice. Clin. Diagn. Lab. Immunol. 11:280-286.
20. Mukherjee S, Kashino SS, Zhang Y, Daifalla N, Rodrigues-Junior V, Reed SG, Campos-Neto A. 2005. Cloning of the gene encoding a protective Mycobacterium tuberculosis secreted protein detected in vivo during the initial phases of the infectious process. J. Immunol. 175:5298-5305.
21. Lawn SD. 2012. Point-of-care detection of lipoarabinomannan (LAM) in urine for diagnosis of HIV-associated tuberculosis: a state of the art review. BMC Infect. Dis. 12:103. doi:10.1186/1471-2334-12-103.
22. Dheda K, Davids V, Lenders L, Roberts T, Meldau R, Ling D, Brunet L, van Zyl SR, Peter J, Green C, Badri M, Sechi L, Sharma S, Hoelscher M, Dawson R, Whitelaw A, Blackburn J, Pai M, Zumla A. 2010. Clinical utility of a commercial LAM-ELISA assay for TB diagnosis in HIVinfected patients using urine and sputum samples. PLoS One 5:e9848. doi:10.1371/journal.pone.0009848.
23. Mishra AK, Driessen NN, Appelmelk BJ, Besra GS. 2011. Lipoarabinomannan and related glycoconjugates: structure, biogenesis and role in Mycobacterium tuberculosis physiology and host-pathogen interaction. FEMS Microbiol. Rev. 35:1126-1157.
24. Avrameas S. 1992. Amplification systems in immunoenzymatic techniques. J. Immunol. Methods 150:23-32.
25. Giljohann DA, Mirkin CA. 2009. Drivers of biodiagnostic development. Nature 462:461-464.